an overview of advanced therapies: the uk landscape · an overview of the current issues in the...
TRANSCRIPT
Intended Audience
Medical and Nursing, Scientists, Pharmacists,
Governance, Research, Lab
Further information
Fee FREE TO ATTEND* (T&C’s apply) Register www.www.christie.nhs.uk/soo-
events Email [email protected] Call 0161 918 7409 * Please note that if you book a place and fail to attend without giving at least 7 days notice of cancellation, a £20 cancellation fee will be applied.
An Overview of Advanced Therapies: The UK landscape
Tuesday 22nd October 2019 Education Centre (Dept 17), The Christie, Manchester, M20 4BX
Topics Covered
Malignant indications
Non Malignant Indications
Patient experience
Manufacturing issues
Commissioning of
ATMPs
Governance and Education
Toxicity Management
Overview
An overview of the current issues in the development and delivery of Advanced Therapies, Cell and Gene Therapy, Adoptive Cell Therapies and iMATCH. This study day will increase knowledge on the clinical indications of Advanced Therapies. Delegates will gain an understanding of the complexities of delivering Advanced Therapies in an NHS setting. This will increase awareness of the patient experience and perspective of Advanced Therapy Medicinal Products.
Follow us:
08:30 Registration & Coffee
09:00 Welcome
Dr Jacqueline Barry - Chief Clinical Officer, Cell and Gene Therapy Catapult
09:15 Introduction to iMatch
Dr Fiona Thistlethwaite - Medical Oncology Consultant Experimental Cancer Medicine Team (ECMT), IMATCH Director
09:30 Tumour Infiltrating Lymphocytes Exposed
Prof Roberts Hawkins - Chief Executive Officer and Co-founder of Cellular Therapeutics Ltd, Cellular Therapeutics Ltd
09:55 Cell and Gene Therapy in Paediatric Metabolic Diseases
Prof Robert Wynn - Consultant Paediatric Haematologist & Director of Paediatric Bone Marrow Transplant Programme
Beatriz Duran-Jimenez - Pharmacy Head of Research and Innovation, Manchester University NHS Foundation Trust
10:20 Patient experience of Advanced Therapies
10:45 Coffee Break
Delegates will need to select 1 breakout session from each time slot listed below (please select these through Eventbrite when booking):
11:00 A) What is driving CARTs into the spotlight?
Dr Adrian Bloor - Consultant Haematologist, The Christie
or B) Gene Therapy in Haemophilia
TBC
11:30 C) Oncology adoptive T-Cell therapy - the patient pathway
Tamara Garcia Lopez - Advanced Immune and Cell Therapy Team Leader, The Christie
Michelle Davies - Advanced Nurse Practitioner, The Christie
or D) Cell and Gene Therapy in Haemoglobinapathy
Bluebird
12:00 E) Advanced Therapies in Ophthalmology
TBC
or F) Gene and Cell Therapy in Sickle Cell
TBC
12:30 G) Oncolytic Virus Trial in Lung
Dr Paul Taylor - Pulmonary Oncology Consultant, Manchester University
NHS Foundation Trust
or H) Neurology - Spinal Muscular Atrophy
TBC
Parallel Sessions
An Overview of Advanced Immune Therapies:
The UK Landscape
Follow us:
Delegates will need to select 1 breakout session from each time slot listed below (please select these through Event-brite when booking):
13:45 I) Industry Prospective
TBC Neil Bell - Autoless CEO
or J) ITU considerations and escalation of care
Fiona Dignan - Consultant Haematologist, Manchester University NHS Foundation Trust
14:10 K) NHS England: Commissioning for ATMPs
TBC Steve Williamson - NHS England Lead Cancer Pharmacist
or L) JACIE readiness for Immune Effector Cells
Simon Cliffe - Quality Manager, The Christie
14:30 M) UKMi Horizon Scanning Service
Helen Davies - Director, North West Medicines Information Centre, SPS Horizon Scanning Lead
or N) Addition of ATIMPs onto an Electronic Prescribing System
Zahra Mahmood - Clinical Pharmacist, The Christie
14:50 O) Advanced Cell Therapy Manufacturing
Martine Thomas - GMP Production Manager, Immetacyte
or P) Introducing a Introducing a bespoke ATIMP education package
Michelle Davies - Advanced Nurse Practitioner, The Christie
Laura McNab - Senior Practice Facilitator, Advanced Immune and Cell Therapy, The Christie
15:15 Coffee Break
15:30 Delivery of ATIMPs in the NHS- Governance
Beatriz Duran-Jimenez - Pharmacy Head of Research and Innovation, Manchester University NHS Foundation Trust
Sophia Burgess - Clinical Trials Pharmacist, Manchester University NHS Foundation Trust
15:55 Catapult and ATTC network
Ian Hollingsworth - ATTC Programme Manager, Cell and Gene Therapy Catapult
16:15 Advanced Therapies Apprenticeship Community
Tony Bradshaw - Advanced Therapies Apprenticeships Community Team Project
16:30 Panel Discussion
Prof Fiona Thistlethwaite, Prof Robert Wynn, Michelle Davies, Beatriz Duran-Jimenez,
Dr Kim Linton
16:45 Summary and Close
17:00 Finish
Parallel Sessions Continued
Follow us:
An Overview of Advanced Immune Therapies:
The UK Landscape